X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-14 | ACRV | Acrivon Therapeutics, Inc. | Blume-Jensen Peter | Pres, CEO | P - Purchase | $1.68 | +49,000 | 2,410,477 | +2% | +$82,124 | ||||||
2026-01-14 | NEWT | Newtekone, Inc. | Schwartz Michael Adam | GC | P - Purchase | $13.91 | +2,247 | 49,713 | +5% | +$31,256 | ||||||
2026-01-14 | NEWT | Newtekone, Inc. | Demaria Frank M | Cheif Financial Officer | P - Purchase | $13.91 | +1,556 | 35,220 | +5% | +$21,644 | ||||||
2026-01-14 | NEWT | Newtekone, Inc. | Razon-Feingold Halli | SVP, HR, CAO | P - Purchase | $13.91 | +1,258 | 22,915 | +6% | +$17,499 | ||||||
2026-01-14 | ACRV | Acrivon Therapeutics, Inc. | Levy Adam D. | CFO | P - Purchase | $1.70 | +8,832 | 20,983 | +73% | +$14,999 | ||||||
2026-01-15 | IMRX | Immuneering Corp | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | P - Purchase | $4.57 | +2,298 | 376,496 | +1% | +$10,502 | ||||||
2026-01-16 | YORW | York Water Co | Hand Joseph Thomas | Pres, CEO | P - Purchase | $30.45 | +279 | 39,973 | +1% | +$8,500 | ||||||
2026-01-16 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.43 | +3,496 | 96,181 | +4% | +$5,006 | ||||||
2026-01-16 | YORW | York Water Co | Scarpato Matthew J | COO | P - Purchase | $30.45 | +92 | 964 | +11% | +$2,800 | ||||||
2026-01-14 | CMTV | Community Bancorp /Vt | Brainard Nikole | PAO-Controller | P - Purchase | $22.94 | +100 | 100 | New | +$2,294 | ||||||
2026-01-16 | YORW | York Water Co | Becker Suzanne M | VP- Customer Service | P - Purchase | $30.45 | +46 | 77 | +146% | +$1,400 | ||||||
2026-01-16 | YORW | York Water Co | Chiaruttini Alexandra C | CAO, GC | P - Purchase | $30.45 | +46 | 4,879 | +1% | +$1,400 | ||||||
2026-01-16 | NEOG | Neogen Corp | Nassif Mikheal | CEO | P - Purchase | $9.33 | +137 | 632 | +28% | +$1,279 | ||||||
2026-01-16 | YORW | York Water Co | Grimm Ashley M | VP- HR | P - Purchase | $30.45 | +14 | 335 | +4% | +$420 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |